Published:
Novo Nordisk said game on, as the Denmark-based drugmaker lowered prices on its obesity treatment Wegovy for those without insurance, and said it would deliver the drug to their homes.
The company’s
NVO move comes a week after Eli Lilly & Co. LLY cut prices for its rival weight-loss drug Zepbound.
Read the full article here